6 results
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... 100 cells/mm3 g/mL ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Recommendations for Preventing ... if MIC<0.12 ug/ml ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
suspension 4–6 mL ... mucosal #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
Infection (Diffuse Pulmonary ... Coccidiodomycosis #IDSA #Prevention ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
and Treating HHV ... Castleman’s Disease (MCD ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
and Treating Varicella ... , 2 doses (0.5 mL ... #Treatment #management ... #opportunistic ... #infections #HIVAIDS